Skip to content

ORamaVR receives Scale-up Award from Innosuisse to accelerate growth

Life sciences

15 May 2024

ORamaVR is set to enhance its innovative VR solutions for medical training with new support from Innosuisse's Scale-up Coaching program. ORamaVR’s innovative approach to medical training has already made significant impacts in the field, and with the support of Innosuisse and other strategic partners, the company is well-positioned to continue its trajectory of growth and innovation. | © ORamaVR

ORamaVR is set to enhance its innovative VR solutions for medical training with new support from Innosuisse’s Scale-up Coaching program.

Geneva-based ORamaVR has been awarded the prestigious Innosuisse Scale-up Award, granting the company access to the second phase of the Scale-up Coaching program designed to accelerate the growth of high-potential start-ups. Founded in 2016, ORamaVR is at the forefront of virtual reality (VR) solutions for medical training, addressing a critical global shortage of healthcare professionals by providing innovative, immersive training modules.

ORamaVR was initially established in Heraklion, Greece, as a spin-off from the Foundation for Research and Technology-Hellas. In 2020, the company moved its headquarters to Geneva to meet the growing demand for its VR training solutions and to leverage the region’s robust life sciences and technology ecosystem. This strategic relocation was supported by Greater Geneva Bern area (GGBa), OCEI and FONGIT, facilitating ORamaVR’s integration into Western Switzerland’s innovation community.

The company’s proprietary platform, MAGES, is the world’s first hyper-realistic VR-based software designed to accelerate medical training and assessment. MAGES allows for the creation of high-quality, cost-effective medical training modules that significantly reduce the time and resources typically required for developing such content. This technology has been pivotal in various collaborative projects, including partnerships with the University of Bern, the Geneva University Hospitals (HUG), and several international institutions.

In 2023, ORamaVR was part of Innosuisse’s “PROFICIENCY” project, which received CHF 12 million to advance surgical simulation training. The project aims to shift practical training in surgery from the operating room to standardized, proficiency-based curricula utilizing VR and augmented reality (AR) technologies. This initiative highlights ORamaVR’s commitment to revolutionizing medical education through cutting-edge technology.

The recent Innosuisse Scale-up Award not only validates the company’s growth and innovation but also provides essential support for its future expansion. With the Scale-up Coaching program, ORamaVR will receive specialized guidance in areas such as organizational growth, regulatory affairs, fundraising, and investor relations, helping the company scale its operations and expand its market reach both within Switzerland and internationally.